| 000 | 01790 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513223002.0 | ||
| 264 | 0 | _c20001121 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0270-9139 | ||
| 024 | 7 |
_a10.1053/jhep.2000.19287 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, S H | |
| 245 | 0 | 0 |
_aIntrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C. _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _cNov 2000 |
||
| 300 |
_a1089-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP-Binding Cassette Transporters |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChaperonins |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xtherapeutic use |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 |
_aLiver Diseases _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProteins _xgenetics |
| 650 | 0 | 4 |
_aRNA, Double-Stranded _xphysiology |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aSuppression, Genetic |
| 650 | 0 | 4 |
_aVirus Diseases _xprevention & control |
| 650 | 0 | 4 |
_aeIF-2 Kinase _xgenetics |
| 700 | 1 | _aNagayama, K | |
| 700 | 1 | _aEnomoto, N | |
| 700 | 1 | _aIzumi, N | |
| 700 | 1 | _aMarumo, F | |
| 700 | 1 | _aSato, C | |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 32 _gno. 5 _gp. 1089-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/jhep.2000.19287 _zAvailable from publisher's website |
| 999 |
_c10992870 _d10992870 |
||